

Benjami M Lmison, Thelma E. Tupasi and Cleotilde A. Torres
Peter Echevarria, Orasa Suthienkul, David N. Taylor and Chalard Tirapat
Ofelia T. Monzon
Cleotilde A. Torres, Mediadora C. Saniel, Sakai Inouye and Thelma E. Tupasi
Melecia M. Antonio-Velmonte
Corazon O. Rebosa-Manoloto, Soledad L. Mendoza, Joel Escamilla, Marcelo T. Fernando, Richard L. Buck and Catherine P. Ranoa
Manuel B. Zacarias, Bienvenido D. Alora and Lourdes T. Santiago
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Arbidol_Abridged_10May2020_version1_KLR,AFM
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Zinc prophy_Abridged_report_V1 20 APRIL LFD_RFG BLD
For any questions or information, please email: covidrapidreviewteam@gmail.com.
HFNC NIV Abrdiged (26 April 2020) v1.2 CAV
Dr. Jemelyn Garcia, FPCP, FPSMID
Dr. Maria Sonia Salamat, FPCP, FPSMID
Dr. Marja B. Buensalido, FPCP, FPSMID
Dr. Emmerson Gale Vista, FPDS
Dr. Clarisse Garcia-Mendoza, FPDS
Dr. Kingbherly L. Li, FPCP, FPSMID
Dr. Yvette Silubrico, FPCP, FPSMID
Dr. Chatie Olasiman, FPCP, FPSMID
Dr. Ma. Charmian Hufano, FPCP, FPSMID
Dr. Mitzie Lou Osabel, FPCP, FPSMID
Dr. Janice C. Caoili, FPCP, FPSMID
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.